Clinical Trials Logo

Clinical Trial Details — Status: Suspended

Administrative data

NCT number NCT03990207
Other study ID # 2018-OCA-01
Secondary ID
Status Suspended
Phase N/A
First received
Last updated
Start date August 2022
Est. completion date October 2023

Study information

Verified date August 2022
Source Olympus Corporation of the Americas
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To evaluate safety and efficacy


Description:

The purpose of this study is to evaluate the safety and efficacy of the PowerSpiral™ Enteroscopy System, when used in subjects undergoing antegrade (per-oral) enteroscopy of the small bowel.


Recruitment information / eligibility

Status Suspended
Enrollment 100
Est. completion date October 2023
Est. primary completion date June 2023
Accepts healthy volunteers No
Gender All
Age group 22 Years and older
Eligibility Inclusion Criteria: - Patient is = 22 years of age - Medical indication for antegrade enteroscopy - Willing and able to provide informed consent Exclusion Criteria: - Any medical contraindication to standard enteroscopy - Any test that is done as part of the standard of care that would prevent the enteroscopy from being performed for safety reasons - Unable or unwilling to provide informed consent - Female and of child-bearing age who is currently pregnant or planning to become pregnant within the study period - Presence of any intra-luminal or extra-luminal foreign body in the abdominal cavity - Any prior gastric, small bowel or colonic surgery, or implantable devices in these locations (cardiac pacemakers and non-abdominal implants are acceptable) - Known or suspected bowel obstruction, or history of bowel obstruction - Taking anti-platelet agents or anticoagulants (other than aspirin) within last 7 days - Known coagulation disorder - Known or suspected esophageal stricture or Schatzki ring - Known gastric or esophageal varices - Suspected perforation of the gastrointestinal (GI) tract - Previous abdominal radiation - Inability to tolerate general anesthesia for any reason - Inability to tolerate endotracheal intubation - Known need for endoscopic retrograde cholangiopancreatography (ERCP) during enteroscopy - American Society of Anesthesiologists (ASA) Classification 4 or greater

Study Design


Related Conditions & MeSH terms


Intervention

Device:
PowerSpiral Enteroscopy System
Motorized spiral enteroscopy system

Locations

Country Name City State
United States Olympus Corporation of the Americas Southborough Massachusetts

Sponsors (6)

Lead Sponsor Collaborator
Olympus Corporation of the Americas AdventHealth, Baylor Research Institute, Rhode Island Hospital, University of Florida, University of Massachusetts, Worcester

Country where clinical trial is conducted

United States, 

References & Publications (4)

Akerman PA, Haniff M. Spiral enteroscopy: prime time or for the happy few? Best Pract Res Clin Gastroenterol. 2012 Jun;26(3):293-301. doi: 10.1016/j.bpg.2012.03.008. Review. — View Citation

Baniya R, Upadhaya S, Subedi SC, Khan J, Sharma P, Mohammed TS, Bachuwa G, Jamil LH. Balloon enteroscopy versus spiral enteroscopy for small-bowel disorders: a systematic review and meta-analysis. Gastrointest Endosc. 2017 Dec;86(6):997-1005. doi: 10.1016/j.gie.2017.06.015. Epub 2017 Jun 23. Review. — View Citation

Buscaglia JM, Richards R, Wilkinson MN, Judah JR, Lam Y, Nagula S, Draganov PV. Diagnostic yield of spiral enteroscopy when performed for the evaluation of abnormal capsule endoscopy findings. J Clin Gastroenterol. 2011 Apr;45(4):342-6. doi: 10.1097/MCG.0b013e3181eeb74b. — View Citation

Khashab MA, Lennon AM, Dunbar KB, Singh VK, Chandrasekhara V, Giday S, Canto MI, Buscaglia JM, Kapoor S, Shin EJ, Kalloo AN, Okolo PI 3rd. A comparative evaluation of single-balloon enteroscopy and spiral enteroscopy for patients with mid-gut disorders. Gastrointest Endosc. 2010 Oct;72(4):766-72. doi: 10.1016/j.gie.2010.04.043. Epub 2010 Jul 8. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Rate of device related serious adverse events The primary safety endpoint will compare the rate of device related serious adverse events (SAE) reported in this study to the rate of device related SAEs reported in medical literature for the Spirus Medical Endo-Ease Discovery™ SB overtube 7 days
Primary Maximum depth of endoscope insertion The primary efficacy endpoint will compare the maximum depth of enteroscope insertion for the study device to the maximum depth of enteroscope insertion data reported in medical literature for the Spirus Medical Endo-Ease Discovery™ SB overtube. Intraoperative
Secondary Total procedure time Measured from initial enteroscope introduction through the bite block to final enteroscope withdrawal through the bite block in minutes. Intraoperative
Secondary Insertion time Measured from the initial enteroscope introduction through the bite block to maximum depth of enteroscope insertion measured in minutes Intraoperative
Secondary Withdrawn time Measured from maximum depth of enteroscope insertion excluding any time spent on therapeutic interventions, to final enteroscope withdrawal through bite block measured in minutes. Intraoperative
Secondary Total enteroscopy rate Percentage of subjects where the entire small intestine is intubated with the enteroscopy from pylorus to cecum. Intraoperative
Secondary Diagnostic yield Percentage of subjects where enteroscopy produces the findings required to establish diagnosis. Intraoperative
Secondary Adverse events SAEs regardless of relationship to study device and/or procedure, and non-SAEs related to study device and/or procedure 7 days post-procedure
Secondary Device deficiencies Number of device deficiencies during the enteroscopy procedure Intraoperative
See also
  Status Clinical Trial Phase
Completed NCT05086471 - Performance Evaluation of the NaviCam SB Capsule Endoscope System for the Diagnosis of Small Bowel Diseases N/A
Completed NCT05548140 - Novel Motorized Spiral Enteroscopy Vs Single Balloon Enteroscopy In Patients With Small Bowel Disorders- A RCT N/A
Completed NCT03955081 - A Clinical Study With the Medical Device PowerSpiral for Deep Enteroscopy
Recruiting NCT03321669 - Impact of Diet on Capsule Endoscopy N/A
Completed NCT04186390 - Learning Small Bowel Capsule Endoscopy
Recruiting NCT04152239 - Utility of Motorized Spiral Enteroscopy for Suspected Small Bowel Pathology
Completed NCT01088646 - Evaluation of PillCam® Express Capsule Endoscopy Delivery System N/A
Not yet recruiting NCT05522101 - Mini-sized MCE for Detection of Small Bowel in Children Under the Age of 10 Years N/A
Completed NCT05182983 - Tongue Image Database and Diagnostic Model for Digestive Tract Disease Diagnosis
Completed NCT04884113 - PowerSpiral Enteroscopy Performance and Safety
Recruiting NCT04959994 - Small Bowel Evaluation Using Novel Motorized Spiral Enteroscopy
Completed NCT03482661 - Magnetic Steering Improves Small Bowel Capsule Endoscopy Completion Rate N/A
Not yet recruiting NCT05408910 - Rifaximin for Treatment of Bloating in Children and Adults With Cystic Fibrosis Phase 2/Phase 3
Completed NCT02486536 - The Best Dosage and Timing of Polyethylene Glycol for Bowel Preparation Before Capsule Endoscopy Phase 4
Recruiting NCT05004207 - Study of Oro-cecal Transit Time in Healthy Subjects Using Scintigraphy and Lactulose Hydrogen Breath Test.
Recruiting NCT00275184 - Bowel Preparation and Prokinetics in Capsule Endoscopy Phase 3
Recruiting NCT06111131 - Ancora-SB Overtube Complete Positioning and Optical Visualization During Endoscopic Procedures N/A
Completed NCT05228379 - Small Bowel Capsule Endoscopy: Experience From a Single Large Tertiary Care Centre
Not yet recruiting NCT03438695 - Total Motorized Spiral Enteroscopy Trial N/A
Recruiting NCT03962283 - Rifaximin and Misoprostol Combination Therapy for Healing of Small Bowel Ulcers in Aspirin Users Phase 2/Phase 3